Chemical Compound
Acetamide, N-[3-[3-cyclopropyl-5-[(2-fluoro-4-iodophenyl)amino]-3,4,6,7-tetrahydro-6,8-dimethyl-2,4,7-trioxopyrido[4,3-d]pyrimidin-1(2H)-yl]phenyl]-, compd. with 1,1'-sulfinylbis[methane] (1:1); GSK 1120212B; Trametinib dimethyl sulfoxide; GSK 1120212B
CAS Registry Number
1187431-43-1
Primary record
Acetamide, N-[3-[3-cyclopropyl-5-[(2-fluoro-4-iodophenyl)amino]-3,4,6,7-tetrahydro-6,8-dimethyl-2,4,7-trioxopyrido[4,3-d]pyrimidin-1(2H)-yl]phenyl]-, compd. with 1,1'-sulfinylbis[methane] (1:1); GSK 1120212B; Trametinib dimethyl sulfoxide; GSK 1120212B
- 库存
- 1,648 克
- 纯度
- 98.1 %
- CAS
- 1187431-43-1
化合物标识与属性
- CAS
- 1187431-43-1
- PubChem CID
- 50992434
- SMILES
- CC1=C2C(=C(N(C1=O)C)NC3=C(C=C(C=C3)I)F)C(=O)N(C(=O)N2C4=CC=CC(=C4)NC(=O)C)C5CC5.CS(=O)C
- Canonical SMILES
- CC(=O)Nc1cccc(-n2c(=O)n(C3CC3)c(=O)c3c(Nc4ccc(I)cc4F)n(C)c(=O)c(C)c32)c1.CS(C)=O
名称与同义词
- Trametinib DMSO
- Trametinib DMSO solvate
- TRAMETINIB DIMETHYL SULFOXIDE
- Trametinib
- 1187431-43-1
- Mekinist
- Mekinst
- Trametinib (DMSO solvate)
- UNII-BSB9VJ5TUT
- Spexotras (TN)
- BSB9VJ5TUT
- Mekinist (TN)
- GSK1120212B
- Trametinib Impurity 28
- RefChem:57976
- Trametinib DMSO solvate?
- CHEBI:75991
- GSK-1120212B
- GSK1120212 (DMSO solvate)
- C28H29FIN5O5S
- GSK1120212
- DTXSID30152223
- JTP 74057
- Trametinib dimethyl sulfoxide [USAN]
- orb1301426
- SCHEMBL1516331
- CHEMBL2105741
- DTXCID0074714
- SCHEMBL29786139
- GSK 1120212B
- MFCD21609250
- OQUFJVRYDFIQBW-UHFFFAOYSA-N
- C26H23FIN5O4.C2H6OS
- GLXC-90089
- HMS5086F12
- GSK-1120212 (DMSO solvate
- AMY30057
- AOB87798
- BCP06093
- EX-A5800
- KS-00000LF6
- 4126AH
- HY-10999A
- s4484
- AKOS027338667
- ACN-041326
- CS-0061
- EBC-102134
- FT65193
- GSK-1120212
- AC-30850
- AK340973
- AS-17069
- DA-68297
- Trametinib dimethyl sulfoxide (JAN/USAN)
- TRAMETINIB DIMETHYL SULFOXIDE [MI]
- TRAMETINIB DIMETHYL SULFOXIDE [JAN]
- A3887
- FT-0696678
- TRAMETINIB DIMETHYL SULFOXIDE [WHO-DD]
- D10176
- W-5848
- N-(3-(3-Cyclopropyl-5-((2-fluoro-4-iodophenyl)amino)-6,8-dimethyl-2,4,7-trioxo-3,4,6,7-tetrahydropyrido[4,3-d]pyrimidin-1(2H)-yl)phenyl)acetamide compound with (methylsulfinyl)methane (1:1)
- ethyl 2-cyano-3-cyclohex-3-en-1-ylprop-2-enoate
- TRAMETINIB DIMETHYL SULFOXIDE [ORANGE BOOK]
- A1212063
- N-(3-(3-Cyclopropyl-5-((2-fluoro-4-iodophenyl)amino)-6,8-dimethyl-2,4,7-trioxo-3,4,6,7-tetrahydropyrido[4,3-d]pyrimidin-1(2H)-yl)phenyl)acetamide dimethyl sulfoxide complex
- Q27145671
- GSK-1120212 DMSO solvate;JTP-74057 DMSO solvate
- N-[3-[3-cyclopropyl-5-(2-fluoro-4-iodoanilino)-6,8-dimethyl-2,4,7-trioxopyrido[4,3-d]pyrimidin-1-yl]phenyl]acetamide;methylsulfinylmethane
- 118745-26-9
- 2,4-Difluoro-N-[2-methoxy-5-[4-(4-pyridazinyl)-6-quinolinyl]-3-pyridinyl]benzenesulfonamide
- 871700-17-3
- Acetamide, N-(3-(3-cyclopropyl-5-((2-fluoro-4-iodophenyl)amino)-3,4,6,7-tetrahydro-6,8- dimethyl-2,4,7-trioxopyrido(4,3-d)pyrimidin-1(2H)-yl)phenyl)-, compd. with 1,1'- sulfinylbis(methane) (1:1)
- ACETAMIDE, N-(3-(3-CYCLOPROPYL-5-((2-FLUORO-4-IODOPHENYL)AMINO)-3,4,6,7-TETRAHYDRO-6,8-DIMETHYL-2,4,7-TRIOXOPYRIDO(4,3-D)PYRIMIDIN-1(2H)-YL)PHENYL)-, COMPD. WITH 1,1'-SULFINYLBIS(METHANE) (1:1)
- Acetamide, N-[3-[3-cyclopropyl-5-[(2-fluoro-4-iodophenyl)amino]-3,4,6,7-tetrahydro-6,8-dimethyl-2,4,7-trioxopyrido[4,3-d]pyrimidin-1(2H)-yl]phenyl]-, compd. with 1,1'-sulfinylbis[methane] (1:1); GSK 1120212B; Trametinib dimethyl sulfoxide; GSK 1120212B
- Equimolecular combination of N-(3-(3-cyclopropyl-5-((2-fluoro-4-iodophenyl)amino)-6,8- dimethyl-2,4,7-trioxo-3,4,6,7-tetrahydropyrido(4,3-d)pyrimidin-1(2H)- yl)phenyl)acetamide with dimethyl-lambda(sup 4)-sulfanone
- GSK-1120212 DMSO solvate;Trametinib;JTP-74057;GSK-1120212;GSK1120212;GSK 1120212;JTP 74057;JTP74057
- N-(3-(3-Cyclopropyl-5-((2-fluoro-4-iodophenyl)amino)-6,8-dimethyl-2,4,7-trioxo-3,4,6,7-tetrahydropyrido(4,3-d)pyrimidin-1(2H)-yl)phenyl)acetamide - (methylsulfinyl)methane (1:1)
- N-(3-(3-cyclopropyl-5-((2-fluoro-4-iodophenyl)amino)-6,8-dimethyl-2,4,7-trioxo-3,4,6,7-tetrahydropyrido(4,3-d)pyrimidin-1(2H)-yl)phenyl)acetamide--(methylsulfinyl)methane (1/1)
- N-(3-(3-cyclopropyl-5-((2-fluoro-4-iodophenyl)amino)-6,8-dimethyl-2,4,7-trioxo-3,4,6,7-tetrahydropyrido[4,3-d]pyrimidin-1(2H)-yl)phenyl)acetamide compound with (methylsulfinyl)methane (1:
- N-(3-(3-cyclopropyl-5-((2-fluoro-4-iodophenyl)amino)-6,8-dimethyl-2,4,7-trioxo-3,4,6,7-tetrahydropyrido[4,3-d]pyrimidin-1(2H)-yl)phenyl)acetamide(methylsulfinyl)methane
- N-(3-(3-cyclopropyl-5-((2-fluoro-4-iodophenyl)amino)-6,8-dimethyl-2,4,7-trioxo-3,4,6,7-tetrahydropyrido[4,3-d]pyrimidin-1(2H)-yl)phenyl)acetamide--(methylsulfinyl)methane (1/1)
- N-(3-{3-cyclopropyl-5-[(2-fluoro-4-iodophenyl)amino]-6,8-dimethyl-2,4,7-trioxo-1H,2H,3H,4H,6H,7H-pyrido[4,3-d]pyrimidin-1-yl}phenyl)acetamide; methanesulfinylmethane
- N-(3-{3-cyclopropyl-5-[(2-fluoro-4-iodophenyl)amino]-6,8-dimethyl-2,4,7-trioxo-3,4,6,7-tetrahydropyrido[4,3-d]pyrimidin-1(2H)-yl}phenyl)acetamide--(methylsulfinyl)methane (1/1)
- N-[3-[3-cyclopropyl-5-(2-fluoro-4-iodo-anilino)-6,8-dimethyl-2,4,7-trioxo-pyrido[4,3-d]pyrimidin-1-yl]phenyl]acetamide;methylsulfinylmethane
- N-{3-[3-Cyclopropyl-5-(2-fluoro-4-iodoanilino)-6,8-dimethyl-2,4,7-trioxo-3,4,6,7-tetrahydropyrido[4,3-d]pyrimidin-1(2H)-yl]phenyl}acetamide--(methanesulfinyl)methane (1/1)